FSSAI suspends nutraceutical maker’s licence
Every batch is manufactured using carefully sourced raw materials, tested under defined quality parameters, and produced under strict hygiene and safety standards. It has also issued notices to several e-commerce platforms. The regulator said these actions are based on consumer complaints, suo motu cognisance and routine enforcement activities carried out by food safety officers.EOMABOUT THE AUTHORRhythma KaulRhythma Kaul works as an assistant editor at Hindustan Times.
- ▪Every batch is manufactured using carefully sourced raw materials, tested under defined quality parameters, and produced under strict hygiene and safety standards.
- ▪It has also issued notices to several e-commerce platforms.
- ▪The regulator said these actions are based on consumer complaints, suo motu cognisance and routine enforcement activities carried out by food safety officers.EOMABOUT THE AUTHORRhythma KaulRhythma Kaul works as an assistant editor at Hindus
Hindustan Times — Top publishes from India and files mainly under world. We currently carry 1,586 of its stories.
Opening excerpt (first ~120 words) tap to expand
HomeNextFSSAI suspends nutraceutical maker’s licenceNew Delhi: The Food Safety and Standards Authority of India (FSSAI) on Friday suspended the manufacturing licence of Rehaan Healthcare after inspections found what the regulator described as “critical non-compliance” and unhygienic conditions at the company’s health supplement and nutraceutical manufacturing unitPublished on: Jul 25, 2026, 08:40:36 ISTBy Rhythma KaulPrefer HTon GoogleShare viaCopy link New Delhi: The Food Safety and Standards Authority of India (FSSAI) on Friday suspended the manufacturing licence of Rehaan Healthcare after inspections found what the regulator described as “critical non-compliance” and unhygienic conditions at the company’s health supplement and nutraceutical manufacturing unit.HT ImageRehaan Healthcare,…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Hindustan Times — Top.
Discussion
0 commentsMore from Hindustan Times — Top
